1,212
Views
6
CrossRef citations to date
0
Altmetric
Letters in Response

Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication

, , , , , & show all
Pages 855-856 | Received 17 Dec 2020, Accepted 22 Dec 2020, Published online: 12 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matthew S. Correia & Robert G. Hendrickson. (2023) Improvement in delirium and visuospatial function after rivastigmine in antimuscarinic toxicity: a case report. Toxicology Communications 7:1.
Read now
Sarah Mahonski, Sanjay Mohan, Mary Ann Howland & Rana Biary. (2022) Antimuscarinic toxicity secondary to moist towelettes containing glycopyrronium tosylate: a case report. Toxicology Communications 6:1, pages 71-73.
Read now

Articles from other publishers (4)

James D. Whitledge, Pelayia Soto, Kieran M. Glowacki, Erin R. Fox & Maryann Mazer-Amirshahi. (2023) Shortages of agents used to treat antimuscarinic delirium. The American Journal of Emergency Medicine 67, pages 163-167.
Crossref
James D. Whitledge, C. James Watson, Michael Simpson, Azza Bakkar, Leora Boussi, Michael Scott & Katherine L. Boyle. (2022) Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine. Journal of Medical Toxicology 19:2, pages 219-223.
Crossref
Jason Seebaluck, Michael A. Downes, Jared Brown, Keith Harris, Katherine Z. Isoardi & Betty S. Chan. (2022) Case series profile of olanzapine post‐injection delirium/sedation syndrome. British Journal of Clinical Pharmacology 89:2, pages 903-907.
Crossref
. (2021) Diphenhydramine. Reactions Weekly 1872:1, pages 180-180.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.